| Literature DB >> 36061362 |
Lorenz S Neuwirth1,2, Michael T Verrengia1,2, Zachary I Harikinish-Murrary1,2, Jessica E Orens1,2, Oscar E Lopez1,2.
Abstract
Behavioral neuroscience tests such as the Light/Dark Test, the Open Field Test, the Elevated Plus Maze Test, and the Three Chamber Social Interaction Test have become both essential and widely used behavioral tests for transgenic and pre-clinical models for drug screening and testing. However, as fast as the field has evolved and the contemporaneous involvement of technology, little assessment of the literature has been done to ensure that these behavioral neuroscience tests that are crucial to pre-clinical testing have well-controlled ethological motivation by the use of lighting (i.e., Lux). In the present review paper, N = 420 manuscripts were examined from 2015 to 2019 as a sample set (i.e., n = ~20-22 publications per year) and it was found that only a meager n = 50 publications (i.e., 11.9% of the publications sampled) met the criteria for proper anxiogenic and anxiolytic Lux reported. These findings illustrate a serious concern that behavioral neuroscience papers are not being vetted properly at the journal review level and are being released into the literature and public domain making it difficult to assess the quality of the science being reported. This creates a real need for standardizing the use of Lux in all publications on behavioral neuroscience techniques within the field to ensure that contributions are meaningful, avoid unnecessary duplication, and ultimately would serve to create a more efficient process within the pre-clinical screening/testing for drugs that serve as anxiolytic compounds that would prove more useful than what prior decades of work have produced. It is suggested that improving the standardization of the use and reporting of Lux in behavioral neuroscience tests and the standardization of peer-review processes overseeing the proper documentation of these methodological approaches in manuscripts could serve to advance pre-clinical testing for effective anxiolytic drugs. This report serves to highlight this concern and proposes strategies to proactively remedy them as the field moves forward for decades to come.Entities:
Keywords: Lux/lighting; behavioral neuroscience tests; elevated plus maze; ethologically motivated controls; light/dark test; open field; rodent pre-clinical screening/testing; three chamber social interaction test
Year: 2022 PMID: 36061362 PMCID: PMC9428565 DOI: 10.3389/fnmol.2022.912146
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 6.261
Figure 1This figure illustrates the flow chart of how the 420 behavioral articles that were searched for to generate an equal representative sample (n = 105 articles of each behavioral test) comprising the Light/Dark Test, Open Field Test, Elevated Plus Maze Test, and the Three Chamber Social Interaction Test were sampled from 2015 to 2019 (n = 20–22 per year; upper dark gray rectangles). Of the N = 420 sampled, only n = 351 met the criteria for animal behavioral test relevance. The publications were then examined for meeting the inclusion criteria for reporting a lighting/Lux value for ethological controls for either anxiogenic or anxiolytic responses (middle light gray rectangles). Next, the refined number of articles were then examined for meeting the inclusion criteria for reporting accurate ranges of lighting/Lux for ethologically relevant stimuli motivation purposes that align with the test’s purpose in the field of behavioral neuroscience (lower light gray rectangles). Through the criteria used, 11.9% of the sampled articles across the behavioral tests were published using appropriate ethological motivational principles (white lowest rectangle) and only n = 50 met the full inclusion criteria, with the Light/Dark Test having better reporting (62.25%), followed by the Open Field (30.09%), then the Elevated Plus Maze (41.41%), and finally the Three Chamber Social Interaction Test with the worst (34.69%) of the respective samples.
Figure 2This figure illustrates the number of publications for the Light/Dark Test, Light/Dark Box Test, and the Open Field Test (A) and the Elevated Plus Maze, Zero Maze Test, and the Three Chamber Social Interaction Test (B) from 2009 to 2019 that populated from Elsevier’s Science Direct search engine. The data show that from 2009 to 2019, across all the behavioral tests noted above, there is a range of 43%–62% increase in their use across the last decade. The most popular behavioral tests used are the Open Field (Gray; A), the Light/Dark Test (Blue; A), followed by the Three Chamber Social Interaction Test (Purple; B), and the Elevated Plus Maze (Yellow; B). The Light/Dark Box Test (Orange; A) and the Zero Maze Test (Green; B) are used less than the Light/Dark Test (Blue; A) and the Elevated Plus Maze (Yellow; B). Across all behavioral tests, the Zero Maze Test was utilized the least (Green; B).
Figure 3This figure illustrates the number of publications that met the criteria for ethologically relevant use of light stimuli (Lux) reported for the Light/Dark Test (L/D T), Open Field Test (OF), the Three Chamber Social Interaction Test (3-CSIT), and the Elevated Plus Maze Test (EPM). The data are presented as Box and Whisker Plots where the mean is represented as (X) the median represented as the line within the boxes (-), the inter-quartile ranges (IQRs) are represented as the lower portion of the whisker to the box (IQR 1), the lower box to the median (IQR 2), the median to the upper box (IQR 3), and the upper box to the upper whisker (IQR 4). The figure also shows a gray dashed line at 300 Lux indicating a threshold for anxiogenic behaviors that occur with light stimuli above this value (red arrow), whereas anxiolytic behaviors occur with light stimuli below the 25 Lux gray dashed line (green arrow). There was one reported outlier for the OF with a Lux of 1,400 reported, otherwise the L/D T, OF, and EPM for the studies that met criteria used comparable Lux as an anxiogenic stimulus range and the 3-CSIT Lux reported were within the anxiolytic stimulus range.
Variations in behavioral tests that met criteria for the Lux reported to motivate anxiety-like behaviors.
| Behavioral test | Animal model | Sex | Lux reported |
|---|---|---|---|
| Elevated Plus Maze Test (EPM) | Long Evans rats (Neuwirth et al., | M and F | 300 |
| Balb/c mice (Estork et al., | M | 400 | |
| Mongolian gerbils and Sprague Dawley rats (Wang S. et al., | M | 350 | |
| Balb/c and Swiss Webster mice (Moreira et al., | M and F | 250–300 | |
| Three Chamber Social InteractionTest (3-CSIT) | Mandarin vole (Wang L. et al., | F | 20 |
| Swiss Webster mice (Crestani et al., | M | 20 | |
| Emx.1Cremice & Sprague Dawley rats (Benekareddy et al., | N/S | 24 | |
| C57Bl/6J mice and A/J mice (Mihara et al., | M | 3–5 | |
| C57Bl/6J mice (Ferri et al., | M | 5 | |
| Sprague Dawley rats (Kerr et al., | M and F | 0 | |
| C57Bl/6J mice and BTBR T + Itpr3tf/J mice (Langley et al., | M and F | 20 | |
| C57Bl/6J mice, BTBR T + Itpr3tf/J mice, 129Sl/SvlmJ mice (Zhang W. et al., | M | 16 | |
| +PA-deficient mice and WT mice (Nakamura K. et al., | M | 10 | |
| Open Field Test (OF) | Balb/c mice (Estork et al., | M | 300 |
| Sprague Dawley rats (Kuniishi et al., | M | 300 | |
| C57Bl/6J mice (Khalil and Fendt, | M and F | 300 | |
| Wistar rats (Casarrubea et al., | M | 300 | |
| Wistar rats (Kawabe, | M and F | 300 | |
| Sprague Dawley rats (Blume et al., | M and F | 250–300 | |
| Sprague Dawley rats (Robinson et al., | M | 530 | |
| California mice (Perea-Rodriguez et al., | M | 1,400 | |
| Long Evans rats (Hetzler et al., | M | 635 | |
| Long Evans rats (Neuwirth et al., | M and F | 300 | |
| Light/Dark Test (L/D) | CD-1 mice (Banaskowski et al., | M | 900 |
| ICR mice (Liu et al., | M | 300 | |
| C57Bl/6J mice (Zhang C. et al., | M | 600 | |
| L1 heterozyhous (L1–/+) mice and WT (L1 +/+) mice (Sauce et al., | F | 300 | |
| XCT−/– mice and xCT +/+ mice with a C57BL/6J genetic background (Bentea et al., | M | 700 | |
| Sprague Dawley rats (Christensen et al., | F | 1,000 | |
| B6 mice (Hicks J. A. et al., | M | 700 | |
| ICR mice (Zhang et al., | M and F | 500 | |
| C57BL/6 N mice (Vogt et al., | M | 600 | |
| Wistar rats and Sprague Dawley rats (Fernandez et al., | M | 400 | |
| C57BL/6JOIaHsd mice& C57BL/6NCrl mice (Labots et al., | M | 650 | |
| Wistar rats (Acevedo et al., | M and F | 400 | |
| Wistar rats (Miranda-Morales and Pautassi, | M and F | 400 | |
| Wistar rats (Farajdokht et al., | M | 1,000 | |
| B6.129S6-Hcrttm1Ywa Orexin-deficient mice (Khalil and Fendt, | M and F | 310 | |
| SP/NKA, HK1, or the NK1 receptor gene-deleted (Tacr1−/–), Tac1 and Tac4 gene-deficient (Tac1−/– and Tac4−/–) mice, and C57 BL/6 mice (Borbely et al., | M | 800 | |
| Swiss Webster mice (Benoit et al., | M | 1,000 | |
| CD-1 out-bred mice (Makinson et al., | M and F | 300 | |
| Balb/c mice (Chandra Sekhar et al., | M | 500 | |
| C57BL/6J mice (Rogers et al., | N/S | 700 | |
| Long Evans rats (Sirohi et al., | M | 600 | |
| Wistar rats (Mahmoudi et al., | M | 1,000 | |
| C57/BL/6Arc mice, SJL mice, Swiss Webster mice, SJL/BL6 mice, C%&BL/6 mice, CD-1 mice, and Sv129 mice (Keenan et al., | M | 934 | |
| C57BL/6NHsd mice, and Balb/vOlaHsd mice (Heinla et al., | F | 550 | |
| Wistar rats (Wille-Bille et al., | M and F | 400 | |
| ICR mice (Zhang and Yao, | M | 400 | |
| Swiss Webster mice (Laureano-Melo et al., | M and F | 400 | |
| ICR mice (Morgan et al., | M | 350 | |
| Wistar rats (Tillmann et al., | M | 350 | |
Note: N/S, not stated in article.